Skip to main content
. 2012 Nov 30;6:1987–1996. doi: 10.2147/OPTH.S35715

Figure 3.

Figure 3

Severity of clinical signs at each visit for patients with Pseudomonas aeruginosa infections at baseline treated with besifloxacin ophthalmic suspension, 0.6%.

Note: Data are the mean (+ standard deviation) severity score for ocular discharge and bulbar conjunctival injection in the study eye rated on a scale of 0–3.